Cloning & Expression Vectors Explained | Recombinant Protein Tech

Added:

Cell-Free Protein Synthesis (CFPS)

While traditional recombinant protein technology relies on cloning genes into expression vectors for in vivo production within living host cells, Cell-Free Protein Synthesis (CFPS) offers a revolutionary alternative. CFPS bypasses the need for living cells, cloning, and vector maintenance by utilizing crude cell extracts containing the necessary transcriptional and translational machinery. This cell-free approach allows for the direct translation of PCR-amplified DNA templates, eliminating time-consuming cloning steps. Additionally, CFPS overcomes major limitations of traditional vector-based expression, such as cellular toxicity of the target protein, physiological constraints of the host organism, and the difficulty of producing complex or non-natural proteins. By operating in an open in vitro environment, researchers gain direct control over the reaction, enabling real-time monitoring, rapid optimization, and the incorporation of unnatural amino acids, presenting a highly efficient alternative to traditional vector-mediated expression systems.

The Central Dogma of Molecular Biology, specifically the mechanisms of DNA transcription and mRNA translation into proteins.
Basic structure and function of plasmid DNA in bacteria, including how plasmids replicate autonomously.
The function of key molecular biology enzymes, particularly restriction endonucleases (restriction enzymes) and DNA ligase.
Concepts of bacterial transformation and selection markers, such as antibiotic resistance genes.
Selecting and optimizing host expression systems, comparing prokaryotic (e.g., E. coli) versus eukaryotic (e.g., yeast, mammalian, or insect cells) systems.
Recombinant protein purification methodologies, such as affinity chromatography using vector-encoded fusion tags (e.g., His-tag, GST-tag).
Industrial bioprocess scale-up, including bioreactor design, optimizing protein yield, and downstream processing.
Advanced therapeutic applications of recombinant proteins, such as the manufacture of monoclonal antibodies, vaccines, and hormone therapies like insulin.
18.3K views164likes57:42@iitOriginal Release: 2011-09-27

Cloning and expression vectors are engineered DNA molecules that enable the introduction and expression of specific genes in host cells to produce recombinant proteins. Expression vectors contain regulatory elements such as promoters and enhancers that drive high-level transcription of inserted genes, allowing the production of therapeutic proteins like insulin, growth hormone, and interferon in microbial and mammalian expression systems. The development of these vectors, pioneered by researchers like Paul Berg, Stanley Cohen, and Herbert Boyer in the 1970s, laid the foundation for the multi-billion dollar biotechnology industry, enabling the production of over 160 approved biotech drugs that have helped more than 325 million people worldwide.